Delivery Order SPE2DB22D3501-SPE2DB25FXB42
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $35,121.23 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 40 mg capsules (30-count packages) valued at $2,332.80, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30 count) with a ceiling value of $1,835.95, effective August 19, 2025, with ultimate completion by August 20, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $20,726.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Isotretinoin...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11.4K to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,016.27 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, with performance to take place at the contractor's Conshohocken, Pennsylvania facility. The contract was awarded without a set-aside designation through competitive procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,388.40 delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (10-count units) with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract value of $2,590.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery...
- The Defense Logistics Agency awarded a $2,522.91 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Isotretinoin 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,482 to Amerisourcebergen Drug Corporation for the supply of 4561971081 Isotretinoin 30 mg capsules. Amerisourcebergen Drug Corporation will deliver 10 capsules under a firm fixed price contract with performance taking place in Conshohocken, Pennsylvania by August 29, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this delivery order supports the Defense Logistics...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXB42Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units) with a ceiling value of $4,685.08. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 28, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that supports global pharmaceutical supply to military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical supplier, maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency covering a broad range of pharmaceutical products and medical supplies for defense healthcare operations. The current order for Isotretinoin, an isotretinoin-based medication used for severe acne treatment, exemplifies the company's ongoing role in fulfilling specialized pharmaceutical needs within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/27/25 |